News & Events

New Feature Provides Suppliers with Research Transparency to Optimize Fulfillment Process

LEXINGTON, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that the Company has launched its new self-service Open Feasibilities Dashboard on iSpecimen Marketplace®, providing expanded access to valuable specimens crucial for advancing medical research.

LEXINGTON, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three- and six-month period ended June 30, 2022.

LEXINGTON, Mass., July 07, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that it has added new global biospecimen suppliers to its proprietary Marketplace platform for advancing oncology and cardiovascular disease research.

LEXINGTON, Mass., June 08, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that the Company has appointed Evan Cox as Vice President of Product Management, effective immediately. In this role, Mr. Cox will manage the growth and future development of the iSpecimen Marketplace™ platform.

LEXINGTON, Mass. – May 19, 2022 – iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), a global online marketplace that connects scientists in need of biospecimens for medical research with healthcare organizations that can provide them, announced today that the Company gave three presentations at this year’s International Society for Biological and Environmental Repositories (ISBER) Annual Meeting in Atlanta, Ga.

LEXINGTON, Mass., April 26, 2022 – iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, online marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare providers who have them, today unveiled its enhanced iSpecimen Marketplace® platform. The new software includes improved search and supplier data integration capabilities that have been designed to efficiently connect scientists with well-matched samples for their research, as well as help to increase supplier inventory utilization.

LEXINGTON, Mass., April 13, 2022 - iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global online biospecimen marketplace that enables life scientists to search across a federated network of healthcare providers for biospecimens needed for medical research, today announced that it added Acutis Diagnostics (“Acutis”), a clinical diagnostics laboratory, to its platform as a laboratory services provider. Through the Acutis relationship, iSpecimen will now offer sequencing services to its research community that can help researchers better understand genetic mutations and their impact on diseases such as COVID-19 and cancer.

- Proprietary Marketplace Provides Easy Access to Urgently-Needed Tissues, Biofluids and Cells for Lifesaving Medical Research -

LEXINGTON, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), a global, proprietary online marketplace connecting scientists with healthcare providers to search for biospecimens needed for medical research, today announced that the Company's network has surpassed 200 healthcare providers.